687 related articles for article (PubMed ID: 28133975)
21. CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications.
Anderson MW; Zhao S; Freud AG; Czerwinski DK; Kohrt H; Alizadeh AA; Houot R; Azambuja D; Biasoli I; Morais JC; Spector N; Molina-Kirsch HF; Warnke RA; Levy R; Natkunam Y
Am J Pathol; 2012 Sep; 181(3):795-803. PubMed ID: 22901750
[TBL] [Abstract][Full Text] [Related]
22. World Health Organization classification of hematopoietic and lymphoid tissues: implications for dermatology.
Russell-Jones R
J Am Acad Dermatol; 2003 Jan; 48(1):93-102. PubMed ID: 12522377
[TBL] [Abstract][Full Text] [Related]
23. The spectrum of peripheral T-cell lymphomas.
O'leary H; Savage KJ
Curr Opin Hematol; 2009 Jul; 16(4):292-8. PubMed ID: 19509496
[TBL] [Abstract][Full Text] [Related]
24. Who is WHO and what was REAL?
Cogliatti SB; Schmid U
Swiss Med Wkly; 2002 Dec; 132(43-44):607-17. PubMed ID: 12587044
[TBL] [Abstract][Full Text] [Related]
25. The World Health Organization classification of lymphomas.
Jakić-Razumović J; Aurer I
Croat Med J; 2002 Oct; 43(5):527-34. PubMed ID: 12402390
[TBL] [Abstract][Full Text] [Related]
26. [Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms].
Xiao C; Su ZL; Wu QL; Gao HY; Fang JC; Xia ZJ; Guan ZZ
Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):22-7. PubMed ID: 15796877
[TBL] [Abstract][Full Text] [Related]
27. Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms.
Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J
Ann Oncol; 2000; 11 Suppl 1():3-10. PubMed ID: 10707771
[TBL] [Abstract][Full Text] [Related]
28. The applicability of the new WHO-EORTC classification of primary cutaneous lymphomas to a single referral center.
Khamaysi Z; Ben-Arieh Y; Izhak OB; Epelbaum R; Dann EJ; Bergman R
Am J Dermatopathol; 2008 Feb; 30(1):37-44. PubMed ID: 18212543
[TBL] [Abstract][Full Text] [Related]
29. Extranodal malignant lymphoma of the upperaerodigestive tract in King Chulalongkorn Memorial Hospital according to WHO classification.
Assanasen T; Wannakrairot P; Keelawat S; Pramprayoon N; Chaipipat M
J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S249-54. PubMed ID: 16083197
[TBL] [Abstract][Full Text] [Related]
30. [Classification of malignant lymphomas. Current situation].
Koch K; Klapper W
Internist (Berl); 2016 Mar; 57(3):206-13. PubMed ID: 26800678
[TBL] [Abstract][Full Text] [Related]
31. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research.
Jaffe ES
Hematology Am Soc Hematol Educ Program; 2009; ():523-31. PubMed ID: 20008237
[TBL] [Abstract][Full Text] [Related]
32. Past, present and future of cutaneous lymphomas.
Cerroni L
Semin Diagn Pathol; 2017 Jan; 34(1):3-14. PubMed ID: 27979336
[TBL] [Abstract][Full Text] [Related]
33. [Revised version of the 4th edition of the WHO classification of malignant lymphomas : What is new?].
Ott G; Klapper W; Feller AC; Hansmann ML; Möller P; Stein H; Rosenwald A; Fend F
Pathologe; 2019 Mar; 40(2):157-168. PubMed ID: 30019203
[TBL] [Abstract][Full Text] [Related]
34. [Overview of 2008 WHO Classification of Malignant Lymphoma].
Nakamura S
Rinsho Byori; 2010 Nov; 58(11):1105-11. PubMed ID: 21229709
[TBL] [Abstract][Full Text] [Related]
35. Class III beta-tubulin shows unique expression patterns in a variety of neoplastic and non-neoplastic lymphoproliferative disorders.
Yoon SO; Kim WY; Go H; Paik JH; Kim JE; Kim YA; Huh JR; Jeon YK; Kim CW
Am J Surg Pathol; 2010 May; 34(5):645-55. PubMed ID: 20220512
[TBL] [Abstract][Full Text] [Related]
36. Malignant lymphoma of the head and neck.
Zapater E; Bagán JV; Carbonell F; Basterra J
Oral Dis; 2010 Mar; 16(2):119-28. PubMed ID: 20374502
[TBL] [Abstract][Full Text] [Related]
37. Canine lymphomas: association of classification type, disease stage, tumor subtype, mitotic rate, and treatment with survival.
Valli VE; Kass PH; San Myint M; Scott F
Vet Pathol; 2013 Sep; 50(5):738-48. PubMed ID: 23444036
[TBL] [Abstract][Full Text] [Related]
38. The problem of classifying lymphomas: an orderly prescription for progress.
Berard CW; Hutchison RE
Ann Oncol; 1997; 8 Suppl 2():3-9. PubMed ID: 9209632
[TBL] [Abstract][Full Text] [Related]
39. Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases.
Economopoulos T; Papageorgiou S; Dimopoulos MA; Pavlidis N; Tsatalas C; Symeonidis A; Foudoulakis A; Pectasides D; Rontogianni D; Rizos E; Chalkia P; Anagnostopoulos A; Melachrinou M; Papageorgiou E; Fountzilas G
Acta Haematol; 2005; 113(2):97-103. PubMed ID: 15802887
[TBL] [Abstract][Full Text] [Related]
40. Studies on the use of membrane markers for the differential diagnosis of malignant lymphomas.
Holowiecki J; Lutz D; Baumgartner G; Hanak H; Knapp W
Oncology; 1979; 36(3):139-43. PubMed ID: 314078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
